Talaris Therapeutics (TALS) News Today → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free TALS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisCompetitorsDividendEarningsHeadlinesInsider TradesOwnershipSocial MediaStock AnalysisCompetitorsDividendEarningsHeadlinesInsider TradesOwnershipSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineLongitude Venture Partners III, L.P.'s Net Worthbenzinga.com - February 25 at 9:31 PMRA Capital Management L.P. Takes Position in Talaris Therapeutics, Inc. (NASDAQ:TALS)marketbeat.com - December 12 at 9:44 AMTalaris Therapeutics (TALS) Price Target Increased by 562.50% to 135.15msn.com - November 1 at 8:40 AMTalaris Therapeutics goes ex-dividend tomorrowmsn.com - October 19 at 3:47 PMTalaris Therapeutics, Inc.: Talaris Therapeutics Announces Stockholder Approval of Merger with Tourmaline Biofinanznachrichten.de - October 18 at 8:02 AMTalaris shareholders approve merger, 1-for-10 reverse stock splitmsn.com - October 17 at 10:28 PMTalaris Therapeutics Announces Stockholder Approval of Merger with Tourmaline Biofinance.yahoo.com - October 17 at 10:28 PMShares of Talaris Therapeutics Climb 5.2% on Special Dividend Tied to Mergermarketwatch.com - October 6 at 8:19 PMTalaris Therapeutics Declares Special Dividend In Connection with Proposed Merger with Tourmaline Biofinance.yahoo.com - October 6 at 8:19 PMNew York Blood Center Enterprises Acquires Commercial-Scale Cell & Gene Therapy Development and Manufacturing Facilities from Talaris Therapeuticsfinance.yahoo.com - October 4 at 9:59 AMWe're Keeping An Eye On Talaris Therapeutics' (NASDAQ:TALS) Cash Burn Ratefinance.yahoo.com - September 12 at 5:34 PMAcadian Asset Management LLC Raises Holdings in Talaris Therapeutics, Inc. (NASDAQ:TALS)marketbeat.com - September 7 at 5:23 AMSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AEL, DEN, TALS, QUOTmarkets.businessinsider.com - August 15 at 6:25 PMImmunoFree Inc. has Acquired Talaris Therapeutics, Inc.'s Tolerance Businessfinance.yahoo.com - August 14 at 3:38 PMSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NEX, TALS, QUOT, SURFmarkets.businessinsider.com - August 8 at 8:33 AMMoore Kuehn Encourages RETA, TALS, INPX, and DEN Investors to Contact Law Firmbenzinga.com - July 28 at 4:44 PMSHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Talaris Therapeutics, Inc. (TALS)markets.businessinsider.com - July 27 at 11:10 AMSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NETI, QUOT, TALS, CFMSmarkets.businessinsider.com - July 18 at 1:26 PMTalaris Therapeutics: Cashing Out Ahead Of Tourmaline Mergermsn.com - July 18 at 8:26 AMShort Interest in Talaris Therapeutics, Inc. (NASDAQ:TALS) Decreases By 71.7%marketbeat.com - July 14 at 5:24 PMTalaris Therapeutics (TALS) Price Target Increased by 66.67% to 12.75msn.com - July 6 at 8:45 PMIMPORTANT ALERT: Halper Sadeh LLC Investigates TALS, DICE, NEX, NETImarkets.businessinsider.com - June 27 at 7:57 AMTALARIS THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Talaris Therapeutics, Inc. - TALSbusinesswire.com - June 26 at 11:07 PMSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Talaris Therapeutics, Inc. Mergerbenzinga.com - June 23 at 7:17 PMTalaris Therapeutics announces merger after layoffsbizjournals.com - June 23 at 9:16 AMNY biotech to go public by merging with Boston firm that laid off 95% of staffbizjournals.com - June 22 at 11:54 PMTalaris jumps 29% on merger with Tourmaline Bio in all-stock dealmsn.com - June 22 at 6:54 PMIMPORTANT ALERT: Halper Sadeh LLC Investigates TALS, SURF, NEX, CIRmarkets.businessinsider.com - June 22 at 6:54 PMTalaris Therapeutics, Inc.: Talaris Therapeutics and Tourmaline Bio Announce Merger Agreementfinanznachrichten.de - June 22 at 1:54 PMTalaris Soars on All Stock Deal with Tourmaline Biomsn.com - June 22 at 1:54 PMTALS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Talaris Therapeutics, Inc. Is Fair to Shareholdersstockhouse.com - June 22 at 1:54 PMWhy Talaris Therapeutics Stock Is Shooting Higher Todaybenzinga.com - June 22 at 1:54 PMTalaris to merge with Tourmaline Bio in all-stock dealseekingalpha.com - June 22 at 8:53 AMTourmaline, Talaris Announce All-stock Mergermarkets.businessinsider.com - June 22 at 8:53 AMTalaris Therapeutics and Tourmaline Bio Announce Merger Agreementfinance.yahoo.com - June 22 at 8:53 AMmarketbeat.com - June 22 at 7:26 AMTalaris Therapeutics Board Member Awarded $50K Worth of Stock Optionsbenzinga.com - June 15 at 3:41 PMTalaris Therapeutics Director Awarded $50K Worth of Stock Optionsbenzinga.com - June 15 at 3:41 PMTalaris Therapeutics, Inc. (NASDAQ:TALS) Director Sells $62,530.74 in Stockmarketbeat.com - June 9 at 7:49 PMTalaris Therapeutics, Inc.: Talaris Therapeutics Announces Leadership Transitionfinanznachrichten.de - May 26 at 11:51 AMTalaris Therapeutics Names Mary Kay Fenton Interim CEO & President - Quick Factsmarkets.businessinsider.com - May 26 at 11:51 AMTalaris Therapeutics appoints current CFO Mary Kay as interim CEOmsn.com - May 26 at 11:51 AMTalaris Therapeutics Announces Leadership Transitionfinance.yahoo.com - May 26 at 11:51 AMTalaris Therapeutics, Inc. (NASDAQ:TALS) most popular amongst private equity firms who own 34% of the shares, institutions hold 30%finance.yahoo.com - May 20 at 8:44 AMQ2 2023 EPS Estimates for Talaris Therapeutics, Inc. (NASDAQ:TALS) Increased by SVB Leerinkmarketbeat.com - May 19 at 7:33 AMWellesley biotech announces 2nd round of layoffs this year, closure of Kentucky facilitiesbizjournals.com - May 3 at 10:24 AMTalaris Therapeutics closing Louisville facilities, laying off 51bizjournals.com - May 2 at 7:23 PMTalaris Therapeutics Stock (NASDAQ:TALS), Dividendsbenzinga.com - April 18 at 3:13 PMSVB Securities Reaffirms Their Hold Rating on Talaris Therapeutics (TALS)markets.businessinsider.com - April 5 at 9:56 AMTALS Talaris Therapeutics, Inc.seekingalpha.com - March 21 at 8:09 AM Get Talaris Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TALS and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. TALS Media Mentions By Week TALS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TALS News Sentiment▼0.000.32▲Average Medical News Sentiment TALS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TALS Articles This Week▼01▲TALS Articles Average Week Get Talaris Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TALS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CARGO Therapeutics News Cabaletta Bio News REGENXBIO News Cullinan Oncology News Immatics News Relay Therapeutics News BioCryst Pharmaceuticals News HilleVax News Kyverna Therapeutics News Prime Medicine News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TALS) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithMan Who Predicted 2008: “This Will be Worse.”AltimetryFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Talaris Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
